Key Takeaways Bruker received $10M in new NMR instrumentation orders from NYSBC, Delaware, and Northwestern. BRKR's systems, backed by NIH and NSF funding, will be delivered and installed in 2026. The new orders strengthen Bruker's BioSpin segment and lifted shares 6.2% to $36.98. Bruker Corporation (BRKR) recently received new orders for advanced Nuclear Magnetic Resonance (“NMR”) instrumentation from the New York Structural Biology Center (“NYSBC”), the University of Delaware and Northwestern University. ...